Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Neoplasms 1Lymphoma 1Immunotherapy Esophagus Cancer 1Hypopharyngeal Neoplasms 1Hepatic Artery Infusion 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Cisplatin 20Surgical Procedures, Operative 9Docetaxel 8Cetuximab 8Radiotherapy, Intensity-Modulated 7Magnetic Resonance Spectroscopy 6pembrolizumab 5Specimen Handling 5Radiotherapy 5Fluorouracil 5toripalimab 4Surveys and Questionnaires 4Radiation 4Paclitaxel 4Chemoradiotherapy 4Celecoxib 4X-Rays 3Platinum 3Counseling 3Carboplatin 3130-nm albumin-bound paclitaxel 31,2-diaminocyclohexaneplatinum II citrate 3camrelizumab 2Taxes 2Standard of Care 2Psychiatric Rehabilitation 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Narrow Band Imaging 2Interviews as Topic 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypopharyngeal Neoplasms × nedaplatin × Clear all
NCT05860335 2024-02-20

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Chinese PLA General Hospital

Phase 2 Unknown
30 enrolled
Head & Neck

Hypopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡